97 related articles for article (PubMed ID: 3178171)
21. Phylloid breast tumors and three steroid hormone receptors.
Lang BA; Vermousek I; Simicková M; Cernoch M; Nekulová M; Paćovský Z; Rejthar A
Neoplasma; 1997; 44(1):53-7. PubMed ID: 9201281
[TBL] [Abstract][Full Text] [Related]
22. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
[TBL] [Abstract][Full Text] [Related]
23. Is triple negative a prognostic factor in breast cancer?
Nishimura R; Arima N
Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
[TBL] [Abstract][Full Text] [Related]
24. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
[TBL] [Abstract][Full Text] [Related]
25. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
26. [Receptor status and ovarian function in carcinoma of the breast].
Giuffrida D; La Porta GA; Sicurella C; La Rosa GL; Milazzo G; Foti E; Marchese V; Lanza C; Vigneri R; Belfiore A
G Ital Oncol; 1989; 9(2-3):73-6. PubMed ID: 2767731
[TBL] [Abstract][Full Text] [Related]
27. Hormone receptors and Japanese breast cancer.
Matsumoto K; Kitamura Y; Sugano H
Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
[TBL] [Abstract][Full Text] [Related]
28. Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.
Lumachi F; Basso SM; Brandes AA; Pagano D; Ermani M
Anticancer Res; 2004; 24(5B):3221-4. PubMed ID: 15510614
[TBL] [Abstract][Full Text] [Related]
29. A multifactorial analysis of different biological and clinical parameters in breast cancer.
Toma S; Coialbu T; Bonassi S; Nicolò G; Rosso R
Anticancer Res; 1987; 7(3 Pt B):401-7. PubMed ID: 3631893
[TBL] [Abstract][Full Text] [Related]
30. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
Pewnim T; Adams JB; Ho KP
Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
[TBL] [Abstract][Full Text] [Related]
31. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
Fernandez MD; Alaghband-Zadeh J; Burn JI
Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
[TBL] [Abstract][Full Text] [Related]
32. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I
Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434
[TBL] [Abstract][Full Text] [Related]
33. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
[TBL] [Abstract][Full Text] [Related]
34. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of prolactin receptors in human breast cancer.
Bonneterre J; Peyrat JP; Beuscart R; Lefebvre J; Demaille A
Cancer Res; 1987 Sep; 47(17):4724-8. PubMed ID: 3621169
[TBL] [Abstract][Full Text] [Related]
36. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer.
Fuqua SA; Cui Y
Breast Cancer Res Treat; 2004; 87 Suppl 1():S3-10. PubMed ID: 15597215
[TBL] [Abstract][Full Text] [Related]
38. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].
Bolla M; Chedin M; Chambaz E; Gabelle P
Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331
[TBL] [Abstract][Full Text] [Related]
39. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol.
Khan SA; Sachdeva A; Naim S; Meguid MM; Marx W; Simon H; Halverson JD; Numann PJ
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):867-72. PubMed ID: 10548314
[TBL] [Abstract][Full Text] [Related]
40. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
Thorpe SM
Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
